IL1RL1 rs11208257: Understanding This Genetic Variant
The rs11208257 variant is an intergenic genetic change located near the IL1RL1 gene. Research suggests this variant may influence levels of soluble ST2, a protein involved in immune signaling and allergic responses.
What each genotype means
Typical Soluble ST2 Expression
You carry two copies of the C allele, which is the baseline genotype observed in population studies. This genotype is associated with standard circulating soluble ST2 levels and baseline risk for allergic rhinitis. Evidence for this specific variant is limited and acts as a modest modifier rather than a direct diagnostic indicator.
Carried by approximately 70% to 75% of individuals of European ancestry and is the predominant genotype across most global populations.
Altered Soluble ST2 Levels
You carry one copy of the T allele upstream of the IL1RL1 gene. Large-scale association studies link this allele to modest alterations in soluble ST2 decoy receptor concentrations and a slight change in allergic airway trait sensitivity. Because the overall evidence strength for this variant is limited, this result indicates a small statistical shift rather than a clinical condition.
Carried by roughly 25% of individuals of European ancestry; it occurs at varying lower frequencies in other global ancestries.
Modified Soluble ST2 Profile
You carry two copies of the T allele associated with altered circulating soluble ST2 levels. In research cohorts, this genotype has been evaluated for subtle shifts in allergic rhinitis severity and inflammatory signaling via the IL-33 pathway. Current evidence remains limited and population-specific, meaning it does not determine clinical outcomes or require medical interventions.
Carried by approximately 2% to 3% of individuals of European ancestry, and it is relatively rare in most other populations.
What is rs11208257?
The rs11208257 variant is a single nucleotide polymorphism (SNP) located in an intergenic region of the human genome. Intergenic variants reside in the DNA sequences between genes rather than within the genes themselves. Despite being outside of a protein-coding region, these variants often function as regulatory elements, meaning they can influence how nearby genes are turned on or off. In the case of rs11208257, its proximity to the IL1RL1 gene suggests it may play a role in modulating the expression or activity of that specific gene. Scientists study these non-coding variants to understand how subtle differences in our DNA sequence can contribute to variations in biological traits and disease susceptibility across different individuals.
The Role of the IL1RL1 Gene
The IL1RL1 gene provides instructions for creating a receptor protein that interacts with interleukin-33 (IL-33). This receptor system is a critical component of the immune system, helping to regulate inflammatory responses. When IL-33 binds to its receptor, it triggers a signaling cascade involving proteins like MYD88 and IRAK1/4, which promote immune cell activation. A key feature of this gene is its ability to produce a soluble form of the receptor, often referred to as soluble ST2. This soluble version acts as a decoy, soaking up excess IL-33 and preventing it from activating the membrane-bound receptor. By balancing these signals, the IL1RL1 gene helps maintain immune homeostasis, and variations in this gene or its regulatory regions can potentially alter the intensity of inflammatory responses.
Research and Evidence Strength
Current research into rs11208257 is categorized as having limited evidence regarding its clinical impact. Studies have identified associations between this variant and the levels of circulating soluble ST2 in the blood. Because soluble ST2 is involved in immune regulation, researchers have investigated whether this variant might also be linked to conditions like allergic rhinitis, where the immune system overreacts to environmental triggers. While some studies suggest a potential correlation, the evidence remains preliminary. It is important to note that genetic associations are statistical observations across large groups of people and do not necessarily imply a direct cause-and-effect relationship for any single individual. Further large-scale studies are required to fully clarify the functional consequences of this specific variant and its role in human health.
Population Frequency
The rs11208257 variant is observed across various populations, with a minor allele frequency of approximately 0.15 in individuals of European ancestry. This means that the less common version of the DNA letter at this position appears in about 15% of the chromosomes in that population. Frequency can vary significantly between different ethnic and geographic groups, which is a common finding in human genomics. Understanding these frequency differences is essential for researchers when designing studies to ensure that findings are representative of diverse populations. Because this variant is relatively common, it is frequently included in large-scale genetic association studies aimed at mapping the architecture of complex traits.
What This Information Means for You
Learning about a genetic variant like rs11208257 can be an educational way to understand the complexity of human genetics. However, it is crucial to recognize that this information is for informational purposes only and should not be used for medical diagnosis or to guide personal health decisions. Genetic variants are only one piece of a much larger puzzle that includes environmental factors, lifestyle, and other genetic influences. If you have concerns about allergic rhinitis or other inflammatory conditions, you should consult with a qualified healthcare professional. They can provide personalized medical advice based on your clinical history and symptoms. Never change your medication or treatment plan based on genetic data without first discussing it with your doctor or a licensed pharmacist.
How common is this variant?
The minor allele frequency for rs11208257 is approximately 0.15 in European ancestry populations.
Frequently asked questions
Is rs11208257 a cause of allergic rhinitis?
No, rs11208257 is not considered a direct cause of allergic rhinitis. It is a genetic variant that has been statistically associated with the condition in some research, but many other genetic and environmental factors contribute to the development of allergies.
Can I use this SNP to predict my risk of disease?
No, this SNP cannot be used to predict your personal risk of disease. Genetic associations are based on population-level data and do not account for the complex interplay of your unique lifestyle, environment, and overall genetic background.
What does 'intergenic' mean in genetics?
An intergenic variant is located in the DNA sequence between genes. These regions were once called 'junk DNA,' but we now know they often contain important regulatory switches that control how genes are expressed.
Should I talk to my doctor about my rs11208257 genotype?
Generally, there is no clinical need to discuss this specific variant with your doctor. It is currently a subject of scientific research rather than a standard clinical diagnostic marker.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11208257?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL1RL1
This variant in the IL1RL1/IL18R1 locus influences ST2 receptor expression and modifies individual susceptibility to allergic sensitization and asthma.
Intronic regulatory variant in the IL1RL1/IL18R1 cluster modulating ST2 receptor expression and inflammatory disease risk.
ST2/interleukin-1 receptor-like 1 variant associated with altered IL-33 signaling and heightened risk for allergic asthma and atopy.
A regulatory variant within the IL1RL1 (ST2) gene locus associated with allergic rhinitis, eosinophil count regulation, and atopic asthma susceptibility.
Intronic regulatory SNP in IL1RL1/ST2 associated with sST2 expression levels and susceptibility to allergic sensitization and asthma.
Variant in IL1RL1 (ST2) associated with allergic inflammation and cytokine production.